Company Filing History:
3 out of 21,384 
1 out of 121 
Years Active: 2014-2017
Title: Miles Douglas Houslay: Innovator in Prostate Cancer Research
Introduction
Miles Douglas Houslay is a notable inventor based in Renfrewshire, GB. He has made significant contributions to the field of prostate cancer research, holding a total of 3 patents. His work focuses on identifying biomarkers for prostate cancer, which can aid in diagnosis and treatment.
Latest Patents
Houslay's latest patents include innovative methods and compositions for diagnosing and monitoring prostate cancer. One of his key inventions is related to phosphodiesterase 9A (PDE9A), which serves as a marker for prostate cancer. This invention encompasses various methods for diagnosing, detecting, and prognosticating prostate cancer, including hormone-resistant and hormone-sensitive types. Another significant patent involves phosphodiesterase 4D7 (PDE4D7) as a marker for malignant, hormone-sensitive prostate cancer. This invention aims to improve diagnostic accuracy and treatment eligibility for patients suffering from this condition.
Career Highlights
Throughout his career, Houslay has worked with prominent organizations, including Koninklijke Philips Corporation N.V. and the University of Glasgow. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Houslay has collaborated with esteemed colleagues such as Ralf Hoffmann and David James Peter Henderson. These partnerships have further enriched his research endeavors and have led to significant advancements in the understanding of prostate cancer.
Conclusion
Miles Douglas Houslay's innovative work in prostate cancer research highlights the importance of identifying biomarkers for effective diagnosis and treatment. His contributions continue to impact the field and offer hope for improved patient outcomes.